Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts
NEW YORK, August 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts
http://www.reportlinker.com/p0581178/Transdermal-CNS-Therapeutics-Products-Pipeline-Candidates-Markets-Forecasts .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Current disease trends point to increasing morbidity and mortality associated with CNS ailments in the general population. These trends include the growing incidence of neurological disorders associated with longevity and aging, and significant increases in the number of children diagnosed with autism. Because diseases of the central nervous system often result in compromised cognitive and/or motor skills that can increase the level of involuntary non-compliance with therapeutic protocols, transdermal delivery of drugs targeting CNS disorders is generally viewed as a method that can increase patient safety and improve outcomes. In addition to the handful of FDA-approved transdermal CNS products, more than a dozen companies are currently pursuing a range of APIs in transdermal delivery systems that target neurological and CNS conditions. While none of these development-stage candidates is curative, the benefits they can offer in terms of patient ease-of-use, product safety and overall quality-of-care are expected to result in reduced morbidity and more effective symptom management for afflicted patients.
Highlights
- Analyzes and evaluates the global market opportunity for transdermal CNS drugs and assesses the probable impact of evolving regulatory, economic and demand factors
- Assesses transdermal products approved or in development for the delivery of therapeutic drugs for treating central nervous system indications
- Provides detailed descriptions of central nervous system treatment segments, market factors, and business strategies
- Forecasts transdermal CNSt product demand to 2015 by geographic region and product segment
- Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners
Executive Summary
The Current CNS Drug Therapeutics Market
Unmet Needs in CNS Disease Treatment
The Opportunity for Transdermal Delivery of CNS Therapeutics
The CNS Therapeutics Market Opportunity
Changes and Trends in Incidence and Morbidity
The Demand Picture for CNS Therapeutics
Competitive Landscape
Factors Limiting Growth
Transdermal Drug Delivery to the CNS
Patch Designs and Construction
Transdermal Patch Manufacturing and Packaging
The Patch Manufacturing Ecosystem
CNS Patch Economics
Passive vs Active Delivery Systems
The Global Market for Transdermal CNS Therapeutics –Disease Segment Analysis
ADHD
Alzheimer's Disease
Dementia
Depression
Migraine
Nausea
Parkinson's Disease
Restless Leg Syndrome
Schizophrenia
Transdermal CNS Drug Product Analysis and Market Assessments
FDA Approved Transdermal CNS Prescription Products
MAO Inhibitors
Cholinergic Agents
Dopamine Agonists
CNS Stimulants
5-HT3 Receptor Antagonists
Non-FDA Approved Commercial Transdermal CNS Products
Non-U.S. Regional Product Assessment & Market Impact
Strategic Factors and Branding Issues
Development-Stage Transdermal CNS Prescription Products
AChE Inhibitors
Cholinergic Agents
Dopamine Agonists
5-HT3 Receptor Antagonists
Serotonin Agonists
Other Drug Classes
Transdermal CNS Therapeutics Market Data & Forecasts
Market Factors
Regulations and Approvals
Clinical Trials
Indications Prescribing Guidelines and Off-Label Prescribing
Rx-to-OTC Switching
Skin Patch Revenue Models
Market Participant Profiles
Recent Research
Prefilled Syringes
Transdermal Drug Patches
Drug Reconstitution Systems
Events
Drug Delivery Devices (Denmark)
Drug Delivery to the Lungs (UK)
US-Japan Symposium on Drug Delivery Systems (US)
To order this report:
Drug Delivery Technology Industry: Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts
Drug Delivery Technology Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article